By Sarianne Gruber – VP of IBM Watson Health, Dr. Kathleen McGroddy Goetz is focused on technology and commercialization where “the pace has been very busy”. Kathy has been instrumental in many of new acquisitions and partnerships for IBM Watson Health including Phytel, a population health software, and Softlayer for Cloud Computing.
Read More
By Sarianne Gruber – Dr. Kathleen McGroddy Goetz, though she prefers to be called Kathy, describes her career as a journey. A trained academic in healthcare and life sciences with a research perspective, her first aspiration was to do drug discovery.
By Sarianne Gruber – What does it take to scale innovation across a very large enterprise and maximize impact? You might want to ask Marti Nyman. He is the Vice President of Business Development and Commercialization for UnitedHealthcare (UHC). And if you ask Marti what it takes, his answer is the “human touch.”
By Sarianne Gruber – Before we had patient panels and electronic health records, there were patient study logs and regulatory binders. Yet, the same questions are asked today when analyzing study outcomes as yesteryear. How do you assess a treatment, procedure or process for a specific disease in your population sample with the presence of confounding diseases? The answer is a Comorbidity Index.
By Sarianne Gruber – Breaking Media rightly titled this year’s MedCity News conference “Converge”. Listening to the speakers, meeting the founders of new startups and talking to presenters, it became clear that today’s healthcare ecosystem is interdependent on the all the players to move the needle for better quality health.
By Sarianne Gruber – Would you recommend your physician to friend or relative? What would be your reasons for recommending them? Is it because you like the selection of magazines in the waiting room or the self-serve coffee flavors?
By Sarianne Gruber – The deadline is quickly approaching. All interested medical practices can be a part of the Million Hearts Study as long as an application is submitted by September 10, 2015 11:59pm (EDT). This is an excellent opportunity to join a randomized-controlled trial to uncover the best care delivery models that can potentially reduce cardiovascular risk.
By Sarianne Gruber – Pharmaceutical Industry Moves Towards Transparency – The health industry has begun to feel the effects of heightened transparency as consumers, physicians, insurers, pharma and life sciences companies and others become armed with more data.
By Sarianne Gruber – A Virtual Clip Board Pilot Study. Patient self-service kiosks in hospitals and physician offices have helped speed up the patient intake process, collect co-pays as well as improve data quality such errors and duplication of information.